Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan
Takanao Hashimoto, Anju Murayama, Hanano Mamada, Hiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki
Topics & Concepts
GuidelineChristian ministryHealth careConflict of interestFamily medicineMedicineAccountingCoronavirus disease 2019 (COVID-19)Pharmaceutical industryBusinessDiseasePolitical scienceFinancePharmacologyInternal medicineLawPathologyInfectious disease (medical specialty)Pharmaceutical industry and healthcareHealth Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and Policy